Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a leading biopharmaceutical company, delivered its financial results for the fourth quarter and fiscal year, that ended December 31, 2023.
Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023 Read More